Update Artikelilmiah: 21379

LILIANA

NIM

Judul Artikel

Abstrak (Bhs. Indonesia)

Penelitian bertujuan untuk mengetahui efek penambahan fermeherbafit enkapsulasi terhadap panjang dan persentase bobot usus ayam broiler. Materi yang digunakan dalam penelitian ini adalah 80 ekor DOC ayam broiler strain MB (Multi Breeder) 202 Platinum yang dipelihara sampai umur 35 hari. Percobaan dilakukan dengan metode eksperimental in vivo dan menggunakan Rancangan Acak Lengkap. Rancangan terdiri dari 5 perlakuan dan setiap perlakuan diulang sebanyak 4 kali dengan masing-masing ulangan terdiri dari 4 ekor ayam. Perlakuan terdiri dari R0 = penggunaan 0% fermeherbafit enkapsulasi; R1 = penggunaan 1,5% fermeherbafit non-enkapsulasi, R2 = penggunaan 1,5% fermeherbafit enkapsulasi, R3 = penggunaan 3% fermeherbafit enkapsulasi, dan R4 = penggunaan 4,5% fermeherbafit enkapsulasi dalam pakan. Hasil analisis variansi menunjukkan bahwa penambahan fermeherbafit enkapsulasi dalam pakan berpengaruh tidak nyata (p>0.05) terhadap panjang usus duodenum, jejenum dan ileum. Penambahan fermeherbafit enkapsulasi dalam pakan berpengaruh tidak nyata (P>0.05) terhadap persentase bobot usus jejenum dan ileum, tetapi berpengaruh nyata (P<0,05) terhadap persentase bobot usus duodenum. Uji lanjut Beda Nyata Jujur (BNJ) terhadap persentase bobot usus duodenum menunjukkan jika R1 berbeda nyata dengan R3. Dapat disimpulkan bahwa penambahan fermeherbafit hingga level 3% dalam pakan mampu menaikkan persentase bobot usus duodenum hingga 20,7% per bobot hidup. Akan tetapi, penambahan fermeherbafit enkapsulasi sampai level 4,5% dalam pakan menghasilkan panjang usus duodenum, jejenum dan ileum serta persentase bobot usus jejenum dan ileum yang relatif sama.

Abtrak (Bhs. Inggris)

The purpose of this study was to determine the effects of  Fermeherbafit Encapsulation addition in Feed to the Length and Percentage of Intestine Weight of Broiler Chickens. The materials used in this research were 80 DOC broiler chickens strain Multi Breeder (MB) 202 Platinum which are maintained until the age of 35 days. The experiments were performed with in vivo experimental methods and used Completely Randomized Design (CRD). The design consisted of 5 treatments, and each treatment was repeated four times with each replication contained four chickens. The treatment consisted of R0 = feed contained of 0% fermeherbafit encapsulation; R1 = feed contained of 1,5% fermeherbafit non-encapsulation; R2 = feed contained of 1,5% fermeherbafit encapsulation; R3 = feed contained of 3,0% fermeherbafit encapsulation; and R4 = feed contained of 4,5% fermeherbafit encapsulation. Analysis of variance showed that the used of fermeherbafit encapsulation in feed not significant (P>0,05) on length of duodenum, jejenum and ileum intestines. The used of fermeherbafit encapsulation in feed not significant (P>0,05) to percentage of the weight of jejenum and ileum intestines but significant (P<0,05) to percentage of the weight of duodenum intestines. The Further tested of Honesty Significant Difference (HSD) on percentage of the weight of duodenum intestines showed that R1 was significant different with R3. It could be concluded that the addition of fermeherbafit encapsulation up to levels 3% in the feed was able to raised the percentage of the weight of duodenum intestine up to 20,7% per life of weight. However, the addition of fermeherbafit encapsulation up to levels 4.5% in feed produced the length of duodenum, jejenum dan ileum intestines, as well as the percentage of the weight of jejenum and ileum intestines are relatively similar.

Kata kunci

Pembimbing 1

Pembimbing 2

Pembimbing 3

Tahun

Jumlah Halaman